[1]
Weisshaar, E., Sciascia, T. and Stander, S. 2021. Efficacy and Safety of Oral Nalbuphine Extended Release in Prurigo Nodularis: Results of a Phase 2, Randomized, Controlled Trial with an Open Open-Label Extension Phase. SKIN The Journal of Cutaneous Medicine. 5, 1 (Jan. 2021), s29. DOI:https://doi.org/10.25251/skin.5.supp.29.